EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY-NC 4.0

A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy

Cornelia Enzmann, Leonie Steiner, Katarzyna Pospieszny, Christiane Zweier, Kevin Plattner, Dominique Baumann, Bettina Henzi, Elea Galiart, Mirjam Fink, David Jacquier, Georg M Stettner, Paolo Ripellino und 3 weitere

Journal of Neuromuscular Diseases · 03.09.2024 · 11 (5) · 1021-1033

DOI: 10.3233/jnd-240023 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuromuscular Diseases, erschienen am 03.09.2024. Verfasst von Cornelia Enzmann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Muscular Dystrophies, Laminin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

LAMA2-related muscular dystrophy (LAMA2-RD) is an autosomal-recessive disorder and one of the most common congenital muscular dystrophies. Due to promising therapies in preclinical development, there is an increasing effort to better define the epidemiology and natural history of this disease.

Objective

The present study aimed to describe a well-characterized baseline cohort of patients with LAMA2-RD in Switzerland.

Methods

The study used data collected by the Swiss Registry for Neuromuscular Disorders (Swiss-Reg-NMD). Diagnostic findings were derived from genetics, muscle biopsy, creatine kinase-level and electrophysiological testing, as well as from brain MRIs. Further clinical information included motor assessments (CHOP INTEND, MFM20/32), joint contractures, scoliosis, ophthalmoplegia, weight gain, feeding difficulties, respiratory function, cardiac investigations, EEG findings, IQ and schooling.

Results

Eighteen patients with LAMA-RD were included in the Swiss-Reg-NMD as of May 2023 (age at inclusion into the registry: median age 8.7 years, range 1 month – 31 years F = 8, M = 10). Fourteen patients presented with the severe form of LAMA2-RD (were never able to walk; CMD), whereas four patients presented with the milder form (present or lost walking capability; LGMD). All patients classified as CMD had symptoms before 12 months of age and 11/14 before the age of six months. 15 carried homozygous or compound heterozygous pathogenic or likely pathogenic variants in LAMA2 and two were homozygous for a variant of unknown significance (one patient unknown). Brain MRI was available for 14 patients, 13 had white matter changes and 11 had additional structural abnormalities, including cobblestone malformations, pontine hypoplasia and an enlarged tegmento-vermial angle not reported before.

Conclusion

This study describes the Swiss cohort of patients with LAMA2-RD and gives insights into measuring disease severity and disease progression, which is important for future clinical trials, as well as for a better clinical understanding and management of patients with LAMA2-RD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular DystrophiesLamininHumansMaleChildFemaleSwitzerlandCross-Sectional StudiesAdolescentAdultChild, PreschoolYoung AdultInfantRegistriesCohort StudiesMagnetic Resonance Imaging

Stichwörter der Autor:innen

LAMA2Swiss-Reg-NMDcongenital muscular dystrophy. MDC1Anatural history

Substanzen

Lamininlaminin alpha 2

Autor:innen und Institutionen

  • Division of Neuropediatrics and Developmental Medicine, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Division of Neuropediatrics, Children's Hospital, Cantonal Hospital Aarau (KSA), Aarau, Switzerland.
  • Department of Paediatrics, Division of Neuropaediatrics, Development and Rehabilitation, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Department of Human Genetics, Inselspital Bern University Hospital, and University of Bern, Bern, Switzerland.
  • Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Zitieren

APA

Enzmann, C., Steiner, L., Pospieszny, K., Zweier, C., Plattner, K., Baumann, D., Henzi, B., Galiart, E., Fink, M., Jacquier, D., Stettner, G. M., Ripellino, P., Fluss, J., Klein, A., & Swiss-Reg-NMD Group (2024). A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy. Journal of Neuromuscular Diseases, 11(5), 1021-1033. https://doi.org/10.3233/jnd-240023

Vancouver

Enzmann C, Steiner L, Pospieszny K, Zweier C, Plattner K, Baumann D, et al. A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy. Journal of Neuromuscular Diseases. 2024;11(5):1021-1033. doi:10.3233/jnd-240023

BibTeX
@article{Enzmann2024,
  author = {Enzmann, Cornelia and Steiner, Leonie and Pospieszny, Katarzyna and Zweier, Christiane and Plattner, Kevin and Baumann, Dominique and Henzi, Bettina and Galiart, Elea and Fink, Mirjam and Jacquier, David and Stettner, Georg M and Ripellino, Paolo and Fluss, Joel and Klein, Andrea and Swiss-Reg-NMD Group, Swiss-Reg-NMD Group},
  title = {A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy},
  journal = {Journal of Neuromuscular Diseases},
  year = {2024},
  volume = {11},
  number = {5},
  pages = {1021--1033},
  doi = {10.3233/jnd-240023}
}
Kostenlos starten →